. D1 in these malignancies is often secondary to chromoIt therefore seems likely that the oncogenic potential of somal rearrangements or gene amplification events evicyclin D1 overexpression would also be reflected in a distinctive pattern of gene expression, and that an experimentally derived gene expression "signature" could
The population of genes whose levels were highly (Ͼ3-fold change), persistently, and reproducibly affected by cyclin D1 overexpression were identified ( Figure 2B ). Many of the changes in transcript level were apparent soon after the transduced cyclin D1 protein was detectable, and these likely represent a direct effect of cyclin D1 on transcription. Consistent with this, the promoter of one of these genes (HSP70-2) has been shown by others to be specifically activated by cyclin D1 (Kamano and Klempnauer, 1997). Recovery of this known cyclin D1 target gene provided a validation of both the selected experimental conditions and filtering criteria. . An obvious limitation to this, though, is the lack of genes were recovered, of which eight were among those a comprehensive collection of human reference profiles.
already identified as targets of wild-type cyclin D1. And However, it is conceivable that the natural diversity of although the expression characteristics of the remainder genetic alterations in human cancer could be exploited had not satisfied our stringent selection criteria, all five instead to reveal the patterns of gene expression correof these genes were also markedly affected by the wildsponding to perturbation of many different genes. Of type protein ( Figure 2D ). Thus, all 21 genes identified course, the expression profile of a single human tumor were induced by both wild-type and mutant cyclin D1. specimen is likely to be an admixture of the transcripThese were taken as the definitive cyclin D1 expression tional changes reflective of many unknown genetic signature for the remainder of the study. Ribonuclease changes. But given a sufficient number of expression protection assays (RPA) with independently isolated profiles from tumors of various organs, it is conceivable RNA confirmed the effects of cyclin D1 and cyclin D1-that these composite signatures could be deconvoluted KE on eight of eleven target genes tested ( Figure 2E ). to form a virtual compendium of cancer-specific referSimilar results were obtained in the MDA-MB468 human ence profiles.
breast cancer cell line (data not shown). Taken together, Here we present a functional dissection of the mechathese data suggest that the effects of cyclin D1 overexnism of cyclin D1 action based upon the use of gene pression observed do not depend upon cdk4. expression profiling as a global assay for the effects of cyclin D1 overexpression, and describe how the analysis of human tumor gene expression data led to the identifiCyclin D1 Activity in Human Tumors It is conceivable that the expression signature described cation of C/EBP␤ as a principal effector of cyclin D1 activity in human cancer.
above, and the putatively cdk-independent function of cyclin D1 encoded within it, is unique to the experimental cell culture system in which it was defined and not repre- ). KS analysis also allowed us cance of the observation was tested by calculating the frequency at which the statistic on the target gene set to explore the relationship between cyclin D1 levels and E2F-mediated transcription in human tumors. We found was equaled or exceeded in 100,000 trials with 21 genes selected at random from the dataset. that a published set of E2F target genes (Ishida et al., 2001) was not correlated with cyclin D1 in the GCM (p ϭ Using this method, we determined that the expression patterns of our set of target genes were indeed signifi-0.668) ( Figure 3C ). In contrast, these E2F target genes were highly correlated with cyclin D3 expression across cantly correlated with the levels of cyclin D1 in human tumors (p ϭ 0.048). The appearance of most of the tarthe GCM (p ϭ 0.002). This not only provided verification of the E2F target gene set, but also highlights a striking gets early in the ordered list, and how this contributes to a high KS score, is evident from a graphical represendifference between two D-type cyclins considered to exert similar if not identical biochemical activities, furtation of the analysis ( Figure 3A) . The correlation between the levels of cyclin D1 and our set of target genes ther reinforcing the notion that cyclin D1 possesses unique mechanisms of action in human cancer. detected by KS analysis can be appreciated by comparing the pattern of cyclin D1 expression across the entire GCM with those of individual targets ( Figure 3B ). Thus, Discovering Participants in the Mechanism of Cyclin D1 Action: Mining Tumor Gene KS analysis provided evidence that the expression signature identified in vitro had successfully captured a Expression Data The KS metric was used as a data-exploration tool to function of cyclin D1 in vivo, supporting the existence of a cdk-independent activity for cyclin D1 in human compute the degree of coexpression between the genes of the cyclin D1 expression signature and each of the cancer.
No E2F target genes were found among those affected more than 16,000 genes in the GCM. These genes were then ranked by KS score to highlight those with the most by overexpression of wild-type or mutant cyclin D1 in vitro (Figure 2) , despite the fact that this gene set has propitious expression characteristics. A schema of the expression matches an aggregate of those of the genes comprising the cyclin D1 signature can be appreciated by comparing the expression patterns of the 50 genes ranked highest by KSS ( Figure 4B ; see Supplemental Data, Section 2) with those of the 21 gene query set ( Figure 4C ). As anticipated, cyclin D1 was ranked very highly by KSS, being found at position 26 in an ordered list of 16,063 genes. This demonstrates that our analytical method can successfully prioritize a gene whose protein product participates directly in the transcriptional response encoded in the query, and suggests that the list shown in Figure 4B is enriched with such genes. Among the other genes ranked in the top 50 by KSS were at least eight encoding luminal epithelial cell markers (Figure 4B) . Since the majority of solid tumors overexpressing cyclin D1 are of luminal epithelial origin, this also implies that our expression signature had captured the function of cyclin D1 in the most biologically relevant cell-type.
The rapidity of some of the changes in gene expression seen following ectopic overexpression of cyclin D1 in vitro (Figure 2 ) suggested the direct involvement of a transcription factor in the mechanism of cyclin D1 action. Three transcription factor genes-ESE-1b, BTEB2, and C/EBP␤-were identified (www.geneontology.org) among the 50 genes ranked highest by KSS with the GCM (Figure 4B These analyses (Table 1 ) revealed a consistently high ranking for C/EBP␤, but neither BTEB2 nor ESE-1b, in In an attempt to provide direct and independent evi-(A), except that the E2F target gene set was analyzed.
dence for the involvement of C/EBP␤ in the mechanism of cyclin D1 action, we conducted functional analyses of the promoters of genes affected by cyclin D1 overexdata-mining process, which we refer to as KolmogorovSmirnov Scanning (KSS), is provided as Figure 4A . The pression. To avoid potential bias introduced by examining only those genes used to generate the hypothesis, success of KSS in identifying genes whose pattern of DRAL was also excluded by our failure to localize its 2 hr of ectopic wild-type and mutant cyclin D1 being detected (Figures 2A-2C) , and its promoter has already promoter, and since the regulatory sequences of the two HSP70 genes are Ͼ90% identical (see Supplemental been shown to be specifically activated by cyclin D1 (Kamano and Klempnauer, 1997). We therefore took this Data, Section 7), the HSP70-1 promoter was not considered further. The promoter regions of the remaining gene as a template and selected the ten genes whose temporal expression pattern most closely resembled seven genes were cloned upstream of a luciferase cDNA and their responsiveness to cyclin D1 examined by that of HSP70-2 across both independent in vitro experiments ( Figure 5A ). Only three of these ten genes were transfection experiments in MCF-7 cells. Immunoblot analyses confirmed that these cells express C/EBP␤, found in the primary expression signature. Nevertheless, the effects of cyclin D1 and cyclin D1-KE on the expresalthough shorter isoforms were undetectable (data not shown). Only the cyclophilin 40 promoter construct sion of those identified here could be confirmed by RPA ( Figure 5B ). These genes thus provided an independent failed to respond robustly. The other six reporters were activated by cyclin D1 between 2-to 10-fold; the effects cyclin D1 target gene set for validation studies.
E16 and methionyl-tRNA synthetase (metRS) were exof cyclin D1 and cyclin D1-KE were largely indistinguishable ( Figures 6A, 6D , and 6E, and data not shown). cluded from the promoter analysis because their tran-ure 6C). Oligonucleotides representing a number of the We next examined whether C/EBP␤ was involved in ␤⌬Spl to a degree comparable with cyclin D1 itself (Figure 6A) . Remarkably, promoters rendered refractory to cyclin D1 by deletion or mutation were also unresponsive to C/EBP␤⌬Spl, and showed somewhat higher Mapping the sites of cyclin D1 responsiveness by basal activity than their respective wild-type counternested deletion and point mutation ( Figure 6A 
, 1998). pated, while the wild-type promoter was activated by
The similarity of the transcriptional consequences of cyclin D1 and cyclin D1-KE, the mutant promoter was ectopic overexpression of cyclin D1 and the cyclin D1 not ( Figure 6G ). This finding, when taken together with KE mutant, the paucity of E2F target genes in this cyclin the published report, not only provides additional inde-D1 expression signature, and the absence of a correlapendent verification of an involvement of C/EBP␤ in tion between the expression patterns of these E2F target cyclin D1 function, but also indicates that this is likely not genes and cyclin D1 in the GCM argued directly against restricted to the small subset of cyclin D1-responsive activation of cdk4 or sequestration of cdk inhibitor progenes whose promoters were analyzed here.
teins by catalytically inactive cyclin D1/cdk4 complexes Finally, we investigated whether the functional interas the mechanism of cyclin D1 action in human tumors. dependency between cyclin D1 and C/EBP␤ might be It is of course conceivable that a single gene induced attributable to a physical interaction between these two by a cdk-dependent action of cyclin D1 only modestly, proteins. We found that cyclin D1 was efficiently coimor not represented on our microarray, is the sole effector munoprecipitated with C/EBP␤ from the lysates of MCFof cyclin D1-mediated oncogenesis. Equally, since our 7 cells cotransfected with plasmids directing expression cyclin D1 expression signature was established by ecof these proteins, but was undetectable in C/EBP␣ imtopic overexpression in a cell culture system, the fidelity munecomplexes ( Figure 6H ). These data indicate that of this gene set and our conclusion that these changes cyclin D1 can indeed be found specifically in complexes are truly cdk-independent are not, when taken in isolacontaining C/EBP␤, not only providing an additional tion, beyond reproach. However, the remarkable consislayer of evidence in support of an operational connectency with which our set of target genes is found coextion between these proteins but also suggestive of a pressed with cyclin D1 in human tumor specimens model of cyclin D1 function based upon physical contact would appear to make the irrelevance of the mechanism with C/EBP␤. it represents to the malignant phenotype unlikely. We therefore developed a data-mining strategy (KSS) to exploit our experimentally determined expression sigDiscussion nature for the identification of potential participants in the mechanism of cyclin D1 oncogenicity ab initio. A We have employed gene expression profiling to establish the molecular phenotype of cyclin D1 overexprestranscription factor previously unconnected with cyclin D1 was ranked very highly by KSS across a number of sion in a human cell line and used this empirically determined expression signature to study the mechanistic independent tumor gene expression databases. Subsequent functional analyses confirmed that C/EBP␤ was basis of the oncogenic consequences of cyclin D1 over- The significance of S was tested by permutation. For 100,000 trials, expression data are available at www-genome.wi.mit.edu/cancer/ we chose X genes at random from the set of 6,470 and counted pub/cyclin_d1. how often the statistic on our actual data set was equaled or exceeded. The frequency of this event can be taken as a P value. Gene Selection Two methods were used. For Method A, genes were selected on Kolmogorov-Smirnov Scanning (KSS) the following criteria: (1) expression level at any point more than Each gene in a database of interest was used as a prototype. The 4 hr after infection was greater than 3-fold above that in the uninremaining genes were ordered by the Euclidean distance of the fected time-zero control, in both independent experiments; (2) fold vector of their expression pattern from that of the prototype gene, change at a timepoint adjacent to the maximum was at least 2% and a KS score computed for each with the cyclin D1 target gene and no less than 50% of the peak value in each experiment, or the set, as above. Genes were then ranked by their KS score. The expression maximum was at the 24 hr timepoint in both experiments.
process is represented schematically as Figure 4A . Genes whose expression characteristics after transduction of GFP also fulfilled these criteria were then excluded. For Method B, the ten Promoter Analysis genes whose normalized expression vectors from both independent Promoter fragments were recovered from genomic DNA, BAC experiments were separated by the shortest Euclidean distances clones, or plasmid templates by PCR with primers containing synfrom that of HSP70-2 (M59830), after those whose expression level thetic recombination sites and introduced upstream of the luciferase varied less than 2-fold in either of the two experiments had been reporter gene in a modified pGL3-basic (Promega) using Gateway masked, were selected.
cloning 
